The "pRO" mise and "pRO" gress of PROs in cancer clinical trials

Producción científica › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	1544-1546
Número de páginas	3
Publicación	Journal of the National Cancer Institute
Volumen	116
N.º	10
DOI	https://doi.org/10.1093/jnci/djae157
Estado	Published - oct. 1 2024

ASJC Scopus Subject Areas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

@article{392c9003817e4bb18591432e9dd5bce2,

title = "The {"}pRO{"} mise and {"}pRO{"} gress of PROs in cancer clinical trials",

author = "Amrita Basu and Hershman, {Dawn L.}",

year = "2024",

month = oct,

day = "1",

doi = "10.1093/jnci/djae157",

language = "English",

volume = "116",

pages = "1544--1546",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - The "pRO" mise and "pRO" gress of PROs in cancer clinical trials

AU - Basu, Amrita

AU - Hershman, Dawn L.

PY - 2024/10/1

Y1 - 2024/10/1

UR - http://www.scopus.com/inward/record.url?scp=85206018087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85206018087&partnerID=8YFLogxK

U2 - 10.1093/jnci/djae157

DO - 10.1093/jnci/djae157

M3 - Editorial

C2 - 39081236

AN - SCOPUS:85206018087

SN - 0027-8874

VL - 116

SP - 1544

EP - 1546

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 10

ER -